Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anavex Life Sciences

9.30
-0.2000-2.11%
Volume:408.16K
Turnover:3.83M
Market Cap:791.10M
PE:-16.83
High:9.50
Open:9.44
Low:9.26
Close:9.50
Loading ...

Analysts Offer Insights on Healthcare Companies: Anavex Life Sciences (AVXL) and Applied DNA Sciences (APDN)

TIPRANKS
·
28 Feb

When Will Anavex Life Sciences Corp. (NASDAQ:AVXL) Breakeven?

Simply Wall St.
·
26 Feb

Anavex Life Sciences to Present at the 45th Annual TD Cowen Health Care Conference

GlobeNewswire
·
24 Feb

Stock Track | Anavex Life Sciences Soars 5.16% on Analyst's Buy Rating and European Growth Outlook

Stock Track
·
18 Feb

Buy Rating for Anavex Life Sciences Due to Solid Financials and European Market Potential

TIPRANKS
·
18 Feb

Anavex Life Sciences Corp reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
12 Feb

Anavex Life Sciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
12 Feb

Stock Track | Anavex Life Sciences Soars 5.55% Pre-Market on Upbeat Q1 Results, Patent Win for Alzheimer's Drug

Stock Track
·
12 Feb

Anavex Life Sciences Q1 2025 GAAP EPS $(0.14) Beats $(0.19) Estimate, Cash And Cash Equivalents Of $120.8M At December 31, 2024, The Company Anticipates At Current Cash Utilization Rates And Ranges, A Runway Of Approximately 4 Years

Benzinga
·
12 Feb

Anavex Life Sciences: Fiscal Q1 Earnings Snapshot

Associated Press Finance
·
12 Feb

Anavex Life Sciences Corp - Q1 Net Loss $12.1 Million, $0.14 per Share

THOMSON REUTERS
·
12 Feb

Anavex Life Sciences Corp expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
10 Feb

Jim Cramer on Anavex Life Sciences Corp. (AVXL): ‘It’s A Good Spec’

Insider Monkey
·
31 Jan

Anavex put volume heavy and directionally bearish

TIPRANKS
·
29 Jan

Anavex Life Sciences Is Maintained at Buy by D. Boral Capital

Dow Jones
·
28 Jan

Anavex Life Sciences Price Target Maintained With a $42.00/Share by HC Wainwright & Co.

Dow Jones
·
28 Jan

Anavex Life Sciences Announces Issuance of Blarcamesine (Anavex®2-73) Composition of Matter U.S. Patent Expanding Its Intellectual Property Portfolio

THOMSON REUTERS
·
27 Jan

Anavex Life Sciences Stock Skyrockets 95% in 3 Months: Here's Why

Zacks
·
24 Jan

Anavex Life Sciences Price Target Maintained With a $42.00/Share by HC Wainwright & Co.

Dow Jones
·
21 Jan

New Strong Buy Stocks for January 21st

Zacks
·
21 Jan